Literature DB >> 2977418

Metabolism of 3H-dehydroepiandrosterone sulphate by subjects with steroid sulphatase deficiency.

E A Bergner1, L J Shapiro.   

Abstract

Patients with steroid sulphatase deficiency develop ichthyosis with accumulation of cholesterol sulphate in plasma and in the stratum corneum. The present study was undertaken to determine whether desulphation of the C19 steroid DHEAS is also impaired. The mean plasma concentrations of DHEA and androstenedione were significantly lower for patients than for controls (p less than 0.02 and 0.001) while the mean concentration of DHEAS was higher (p less than 0.002). Following intravenous administration of 3H-DHEAS, one patient failed to desulphate 3H-DHEAS as evidenced by an absence of urinary 3H-glucuronides. A second produced normal amounts of urinary 3H-glucuronides (indicative of desulphation capacity) in a baseline study but did not desulphate 3H-DHEAS following ampicillin treatment to alter gut microflora. A third patient had consistent sulphatase activity with and without ampicillin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2977418     DOI: 10.1007/bf01800429

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  33 in total

1.  The multicomponent analysis of conjugates of neutral steroids in urine by lipophilic ion exchange chromatography and computerised gas chromatography-mass spectrometry.

Authors:  K D Setchell; B Almé; M Axelson; J Sjövall
Journal:  J Steroid Biochem       Date:  1976-08       Impact factor: 4.292

2.  Steroid sulfatase deficiency.

Authors:  L J Shapiro; L Cousins; A L Fluharty; R L Stevens; H Kihara
Journal:  Pediatr Res       Date:  1977-08       Impact factor: 3.756

3.  The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man.

Authors:  E Nieschlag; D L Loriaux; H J Ruder; I R Zucker; M A Kirschner; M B Lipsett
Journal:  J Endocrinol       Date:  1973-04       Impact factor: 4.286

4.  Metabolism and interconversion of dehydroisoandrosterone and dehydroisoandrosterone sulfate.

Authors:  R S Rosenfeld; L Hellman; T F Gallagher
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

5.  The assay of cholesterol sulfate in biological material by enzymatic radioisotopic displacement.

Authors:  G Bleau; A Chapdelaine; K D Roberts
Journal:  Can J Biochem       Date:  1972-03

6.  Absorption of oestrone sulphate from the gastrointestinal tract of the rat.

Authors:  D J Back; C R Chapman; S A May; P H Rowe
Journal:  J Steroid Biochem       Date:  1981-04       Impact factor: 4.292

7.  Genetic heterogeneity of steroid sulfatase deficiency revealed with cDNA for human steroid sulfatase.

Authors:  J T Conary; G Lorkowski; B Schmidt; R Pohlmann; G Nagel; H E Meyer; C Krentler; J Cully; A Hasilik; K von Figura
Journal:  Biochem Biophys Res Commun       Date:  1987-04-29       Impact factor: 3.575

8.  Cloning and expression of steroid sulfatase cDNA and the frequent occurrence of deletions in STS deficiency: implications for X-Y interchange.

Authors:  P H Yen; E Allen; B Marsh; T Mohandas; N Wang; R T Taggart; L J Shapiro
Journal:  Cell       Date:  1987-05-22       Impact factor: 41.582

9.  Serum steroid sulphates in ichthyosis.

Authors:  A Ruokonen; A Oikarinen; R Palatsi; I Huhtaniemi
Journal:  Br J Dermatol       Date:  1980-09       Impact factor: 9.302

10.  Placental sulfatase deficiency: a case study.

Authors:  R Osathanondh; J Canick; K J Ryan; D Tulchinsky
Journal:  J Clin Endocrinol Metab       Date:  1976-07       Impact factor: 5.958

View more
  8 in total

1.  Abnormal barrier function in the pathogenesis of ichthyosis: therapeutic implications for lipid metabolic disorders.

Authors:  Peter M Elias; Mary L Williams; Kenneth R Feingold
Journal:  Clin Dermatol       Date:  2012 May-Jun       Impact factor: 3.541

2.  High levels of oxysterol sulfates in serum of patients with steroid sulfatase deficiency.

Authors:  Alberto Sánchez-Guijo; Vinzenz Oji; Michaela F Hartmann; Hans-Christian Schuppe; Heiko Traupe; Stefan A Wudy
Journal:  J Lipid Res       Date:  2014-12-11       Impact factor: 5.922

Review 3.  Pathogenesis-based therapies in ichthyoses.

Authors:  Joey E Lai-Cheong; Peter M Elias; Amy S Paller
Journal:  Dermatol Ther       Date:  2013 Jan-Feb       Impact factor: 2.851

Review 4.  Role of cholesterol sulfate in epidermal structure and function: lessons from X-linked ichthyosis.

Authors:  Peter M Elias; Mary L Williams; Eung-Ho Choi; Kenneth R Feingold
Journal:  Biochim Biophys Acta       Date:  2013-11-27

Review 5.  Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism.

Authors:  Peter M Elias; Mary L Williams; Walter M Holleran; Yan J Jiang; Matthias Schmuth
Journal:  J Lipid Res       Date:  2008-02-02       Impact factor: 5.922

6.  Increased levels of DHEAS in serum of patients with X-linked ichthyosis.

Authors:  A Milone; M Delfino; A Piccirillo; G M Illiano; S M Aloj; M Bifulco
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

7.  Pathogenesis of the cutaneous phenotype in inherited disorders of cholesterol metabolism: Therapeutic implications for topical treatment of these disorders.

Authors:  Peter M Elias; Debra Crumrine; Amy Paller; Marina Rodriguez-Martin; Mary L Williams
Journal:  Dermatoendocrinol       Date:  2011-04-01

Review 8.  The Regulation of Steroid Action by Sulfation and Desulfation.

Authors:  Jonathan W Mueller; Lorna C Gilligan; Jan Idkowiak; Wiebke Arlt; Paul A Foster
Journal:  Endocr Rev       Date:  2015-07-27       Impact factor: 19.871

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.